Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIT-Study: Pegintron Induction Therapy in Chronic HCV Non-Responders
NCT00363259Phase 3Completed
- Sponsor
- Foundation for Liver Research
- Start
- Jul 2002
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised trial of peginterferon alfa-2b in hepatitis C (HCV) (2 arms), sponsored by Foundation for Liver Research. Primary endpoint: Sustained Virological Response. Started Jul 2002; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00363259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363259.